Optimal vaccination schedule search using genetic algorithm over MPI technology
暂无分享,去创建一个
Ferdinando Chiacchio | Francesco Pappalardo | Cristiano Calonaci | F. Pappalardo | F. Chiacchio | C. Calonaci
[1] P. Robbins,et al. A listing of human tumor antigens recognized by T cells , 2001, Cancer Immunology, Immunotherapy.
[2] Francesco Pappalardo,et al. SimB16: Modeling Induced Immune System Response against B16-Melanoma , 2011, PloS one.
[3] Francesco Pappalardo,et al. Optimal vaccination schedules using simulated annealing , 2008, Bioinform..
[4] Kalyanmoy Deb,et al. A Comparative Analysis of Selection Schemes Used in Genetic Algorithms , 1990, FOGA.
[5] Massimo Bernaschi,et al. ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization , 2008, Briefings Bioinform..
[6] G. Parmiani,et al. A listing of human tumor antigens recognized by T cells: March 2004 update , 2005, Cancer Immunology, Immunotherapy.
[7] Francesco Pappalardo,et al. MODELING TUMOR IMMUNOLOGY , 2006 .
[8] Federica Cavallo,et al. Vaccines for tumour prevention , 2006, Nature Reviews Cancer.
[9] C. Bianca,et al. Immune System Network and Cancer Vaccine , 2011 .
[10] Massimo Bernaschi,et al. ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale† , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[11] Piero Musiani,et al. Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine , 2004, Cancer Research.
[12] Melanie Mitchell,et al. An introduction to genetic algorithms , 1996 .
[13] Vladimir Brusic,et al. Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition. , 2012, Journal of immunological methods.
[14] F. Pappalardo,et al. In silico modeling and in vivo efficacy of cancer-preventive vaccinations. , 2010, Cancer research.
[15] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[16] Robert D. Cardiff,et al. Insights from transgenic mouse models of ERBB2-induced breast cancer , 2007, Nature Reviews Cancer.
[17] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[18] Federica Cavallo,et al. Vaccines and other immunological approaches for cancer immunoprevention. , 2011, Current drug targets.
[19] A. Abbas,et al. Cellular and Molecular Immunology , 1991 .
[20] Riccardo Poli,et al. New ideas in optimization , 1999 .
[21] Filippo Castiglione,et al. A Modeling Framework For Immune-related Diseases , 2012 .
[22] P. Musiani,et al. Antimetastatic activity of a preventive cancer vaccine. , 2007, Cancer research.
[23] C. Bianca,et al. The triplex vaccine effects in mammary carcinoma: A nonlinear model in tune with SimTriplex ☆ , 2012 .
[24] Filippo Castiglione,et al. Mathematical and Computational Models in Tumor Immunology , 2012 .
[25] Filippo Castiglione,et al. Vaccine protocols optimization: in silico experiences. , 2010, Biotechnology advances.
[26] Zvia Agur. Biomathematics in the development of personalized medicine in oncology. , 2006, Future oncology.
[27] Federica Cavallo,et al. 2011: the immune hallmarks of cancer , 2011, Cancer Immunology, Immunotherapy.
[28] C. Melief,et al. Cancer immunology. , 2011, Current opinion in immunology.
[29] Filippo Castiglione,et al. Modeling and simulation of cancer immunoprevention vaccine , 2005, Bioinform..
[30] Piero Musiani,et al. Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice , 2001, The Journal of experimental medicine.
[31] Francesco Pappalardo,et al. Modeling the competition between lung metastases and the immune system using agents , 2010, BMC Bioinformatics.